Pure Global

E-tegra Stent Graft System โ€“ Aortic Extension - Abdominal aortic aneurysm stent - ARTG 388372

Access comprehensive regulatory information for E-tegra Stent Graft System โ€“ Aortic Extension - Abdominal aortic aneurysm stent in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 388372 and sponsored by Cryolife Medical (Australia) Company Pty Ltd, manufactured by Jotec GmbH in Germany. The device registration started on May 12, 2022.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class III
ARTG 388372
Class III
E-tegra Stent Graft System โ€“ Aortic Extension - Abdominal aortic aneurysm stent
ARTG ID: 388372
Good Name: Cryolife Medical (Australia) Company Pty Ltd - E-tegra Stent Graft System โ€“ Aortic Extension - Abdominal aortic aneurysm stent
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

The E-tegra Stent Graft System is indicated for the endovasculartreatment of infrarenal aortic aneurysms. These aneurysms can alsoaffect the common iliac artery.

Device Classification
Risk Class
Class III
Product Type
Single Device Product
ARTG Category
General
Registration Information
ARTG ID
388372
Start Date
May 12, 2022
Effective Date
May 12, 2022
Manufacturer
Country
Germany
Address
Lotzenacker 23, Hechingen, 72379